Trial Details
Not RecruitingBasic Information
| Clinical ID | c2175 |
|---|---|
| Identifier | IRCT20191105045340N2 |
| Trial Title | The effect of bromelain supplementation on disease activity and quality of life in patients with inflammatory bowel disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Condition 1: Crohn's disease. Condition 2: Ulcerative colitis. Crohn's disease [regional enteritis] Ulcerative colitis |
| Interventions | Intervention 1: Intervention group: They will receive 2 capsules of 500 (gdu) containing bromelain manufactured by Salamat Parmon Amin company for 8 weeks, 1 hour before or 2 hours after food. Intervention 2: Control group: They will receive 2 capsules of 500 mg containing maltodextrin made by Salamat Parmon Amin company for 8 weeks, 1 hour before or 2 hours after food. |
Participant Information
| Sponsor | Iran University of Medical Sciences |
|---|---|
| City | - |
| Country/Region | Iran |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | interventional |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |